{
    "pmcid": "7857400",
    "qa_pairs": {
        "How much improvement in potency was observed with multivalent nanobody constructs compared to monomeric forms?": [
            "Up to a 30-fold improvement",
            "Up to a 10-fold improvement",
            "Up to a 50-fold improvement",
            "Up to a 5-fold improvement"
        ],
        "What integrative approaches were used to map the epitopes targeted by the nanobodies?": [
            "Size exclusion chromatography (SEC), cross-linking, mass spectrometry, and structural modeling",
            "X-ray crystallography and nuclear magnetic resonance (NMR) spectroscopy",
            "Cryo-electron microscopy and computational docking",
            "Fluorescence resonance energy transfer (FRET) and circular dichroism (CD) spectroscopy"
        ],
        "What was the primary method used to generate a diverse repertoire of nanobodies targeting the SARS-CoV-2 spike protein's receptor binding domain?": [
            "Camelid immunization, specifically using a llama",
            "Mouse hybridoma technology",
            "Phage display library screening",
            "Human B-cell isolation"
        ],
        "What was the range of melting temperatures observed for the nanobodies, indicating their thermostability?": [
            "65.9\u00b0C to 72.8\u00b0C",
            "50.0\u00b0C to 60.0\u00b0C",
            "70.0\u00b0C to 80.0\u00b0C",
            "60.0\u00b0C to 65.0\u00b0C"
        ],
        "Which nanobody demonstrated no detectable dissociation from the RBD during surface plasmon resonance analysis?": [
            "Nb21",
            "Nb15",
            "Nb30",
            "Nb5"
        ]
    }
}